These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16936488)

  • 21. Medicare Program; revisions to the Medicare Advantage and Prescription Drug Benefit programs. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54225-54. PubMed ID: 18985953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Siegel S
    Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
    [No Abstract]   [Full Text] [Related]  

  • 23. One pill, many prices: variation in prescription drug prices in selected government programs.
    Gencarelli DM
    Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (807):1-20. PubMed ID: 16167399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Medicare Prescription Drug Benefit: understanding the benefits and the gaps in this new coverage.
    Baier F
    Am J Nurs; 2006 Jun; 106(6):66-72. PubMed ID: 16728854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacy utilization and the Medicare Modernization Act.
    Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
    Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Introduction.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S2-6. PubMed ID: 17057057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D; Schwarz M
    Inquiry; 2007; 44(2):157-66. PubMed ID: 17850042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicare program; e-prescribing and the prescription drug program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Nov; 70(214):67567-95. PubMed ID: 16273748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.
    AVMA Group Health & Life Insurance Trust
    J Am Vet Med Assoc; 2005 Dec; 227(12):1884-5. PubMed ID: 16382541
    [No Abstract]   [Full Text] [Related]  

  • 33. The Medicare Prescription Drug Improvement and Modernization Act of 2003: summary analysis and preliminary assessment of implications for radiology.
    Moran DW
    J Am Coll Radiol; 2004 May; 1(5):322-30. PubMed ID: 17411596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What will the new medicare drug benefit mean for Minnesota physicians?
    Liebow M
    Minn Med; 2005 Mar; 88(3):38-41. PubMed ID: 15852596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicare Part D: an overview of its practical and clinical impact.
    Usdin S
    Am J Geriatr Cardiol; 2005; 14(6):284-8; quiz 289-90. PubMed ID: 16276124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new Medicare prescription drug benefit: important issues for physician practices.
    Falk R; Stranne S
    J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 39. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first months of the prescription-drug benefit--a CMS update.
    Bach PB; McClellan MB
    N Engl J Med; 2006 Jun; 354(22):2312-4. PubMed ID: 16738266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.